多発性硬化症（Multiple Sclerosis）：疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors 9
3.2.1 Family members of MS patients have a 1%-5% risk of developing MS 9
3.2.2 Women are twice as likely to develop MS, but men have a worse prognosis 9
3.2.3 Caucasians have a higher risk of MS than any other race/ethnicity 10
3.2.4 Protective effect of vitamin D on MS may relate to latitude and month of birth 10
3.2.5 Timing of environmental exposures affects MS risk 11
3.2.6 Exposure to smoking may increase MS risk and worsen prognosis 11
3.3 Comorbidities 12
3.3.1 Autoimmune diseases may be comorbidities of MS 12
3.3.2 Mental comorbidities are found in up to 60% of MS patients and may affect relapse rates 12
3.4 Global Trends 13
3.4.1 North America 13
3.4.2 Europe 14
3.4.3 Asia 15
3.5 Forecast Methodology 16
3.5.1 Sources Used 18
3.5.2 Sources Not Used 24
3.5.3 Forecast Assumptions and Methods 24
3.6 Epidemiological Forecast of Multiple Sclerosis (2013-2023) 34
3.6.1 Total Prevalent Cases of Multiple Sclerosis 34
3.6.2 Age-Specific Prevalent Cases of Multiple Sclerosis 36
3.6.3 Sex-Specific Prevalent Cases of Multiple Sclerosis 38
3.6.4 Total Incident Cases of Multiple Sclerosis 40
3.6.5 Age-Specific Incident Cases of Multiple Sclerosis 42
3.6.6 Sex-Specific Incident Cases of Multiple Sclerosis 44
3.6.7 Multiple Sclerosis Subtypes 46
3.7 Discussion 48
3.7.1 Epidemiological Forecast Insight 48
3.7.2 Limitations of the Analysis 49
3.7.3 Strengths of the Analysis 49
4 Appendix 50
4.1 Bibliography 50
4.2 About the Authors 57
4.2.1 Epidemiologists 57
4.2.2 Reviewers 57
4.2.3 Global Director of Epidemiology 58
4.2.4 Global Head of Healthcare 58
4.3 About GlobalData 59
4.4 About EpiCast 59
4.5 Disclaimer 60